A Phase I Study of Once-Daily Oral DFP-11207 in Patients With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 14 Dec 2017
At a glance
- Drugs DFP 11207 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man
- Sponsors Delta-Fly Pharma
- 08 Dec 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Mar 2018.
- 08 Dec 2017 Status changed from active, no longer recruiting to recruiting.
- 02 Mar 2017 Status changed from recruiting to active, no longer recruiting.